The Shawcross Lab is led by Professor Debbie Shawcross
Chronic liver disease is increasing on a global scale and patients are vulnerable to developing infections and death. The main aim of the lab is to characterise the immune-gut-liver-brain axis in patients and to develop interventions which normalise the abnormal gut microbiome reducing the development of complications and liver failure.
Our Partners
The Francis Crick Institute
European Union
MICROB-PREDICT
Wellcome Trust
